insights_auto
Why is SABS down 3.44%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.81
arrow_downward
-3.44%(-0.10) 1D
$2.81
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$2.79
High
$2.88
Low
$2.64
Mkt. cap
253.15M
Avg. vol.
709.90K
Volume
874.57K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$2.79
High
$2.88
Low
$2.64
Mkt. cap
253.15M
Avg. vol.
709.90K
Volume
874.57K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
The Motley Fool
·
15 minutes ago
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
FOREX.com
·
3 hours ago
S&P 500, Nasdaq 100 Drive into Correction Territory
TradingKey
·
10 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
cwibc.co.id
·
4 hours ago
Wall Street Sell-Off Pushes S&P 500 and Dow Into Correction
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio